Medical Oncology Unit,San Salvatore Hospital,University of L'Aquila,L'Aquila,Italy.
Clinical Division of Palliative Care,Department of Internal Medicine I,Medical University of Vienna,Vienna,Austria.
Palliat Support Care. 2019 Feb;17(1):82-86. doi: 10.1017/S1478951518000238. Epub 2018 May 24.
One of the first steps to early integrate palliative care into oncology practice is a timely and efficient evaluation of symptoms (Bakitas et al., 2015; Davis et al., 2015; Temel et al., 2010). In a recent position paper, the Italian Association of Medical Oncology tells oncologists that they "must be able to prevent, recognize, measure, and treat all cancer-related symptoms" (Zagonel et al., 2017). Major international scientific societies such as the American Society of Clinical Oncology and the European Society of Medical Oncology have often defined the key role of symptoms evaluation and management to force the integration of palliative care into oncology (Davis et al., 2015; Ferrel et al., 2017). Nevertheless, a recent survey conducted by the Italian Association of Medical Oncology shows that only 20% of oncologists regularly uses valid tools to evaluate symptoms, 45% exclusively use them in the context of clinical trials, 30% use them only occasionally, and 5% never use them (Zagonel et al., 2016).
将姑息治疗尽早纳入肿瘤学实践的第一步是及时有效地评估症状(Bakitas 等人,2015 年;Davis 等人,2015 年;Temel 等人,2010 年)。在最近的一份立场文件中,意大利肿瘤医学协会告诉肿瘤学家,他们“必须能够预防、识别、衡量和治疗所有与癌症相关的症状”(Zagonel 等人,2017 年)。主要的国际科学协会,如美国临床肿瘤学会和欧洲肿瘤内科学会,经常定义症状评估和管理的关键作用,以迫使姑息治疗融入肿瘤学(Davis 等人,2015 年;Ferrell 等人,2017 年)。然而,意大利肿瘤医学协会最近进行的一项调查显示,只有 20%的肿瘤学家定期使用有效工具来评估症状,45%仅在临床试验中使用,30%偶尔使用,5%从不使用(Zagonel 等人,2016 年)。